Research shows that dialysis patients with higher vitamin D levels have significantly fewer broken bones. A 2026 study of 292 dialysis patients found that those with lower vitamin D had a 24.3% fracture rate compared to 11.9% in those with adequate levels—nearly double the risk. According to Gram Research analysis, maintaining adequate vitamin D appears to protect bones even in dialysis patients whose kidneys can’t normally activate vitamin D.

A new study of 292 kidney dialysis patients found that those with higher vitamin D levels had significantly fewer broken bones over two years. Researchers discovered that for every small increase in vitamin D, fracture risk dropped by about 17%. Patients with the lowest vitamin D levels were nearly twice as likely to break bones compared to those with adequate levels. According to Gram Research analysis, this finding is important because dialysis patients often have trouble activating vitamin D naturally, yet maintaining good vitamin D levels still appears to protect their bones.

Key Statistics

A 2026 cohort study of 292 hemodialysis patients found that those with lower vitamin D levels had a 24.3% fracture rate over 24 months, compared to 11.9% in patients with higher vitamin D levels, representing an 87% increased fracture risk.

Research published in 2026 showed that every 10 nmol/L increase in serum vitamin D levels reduced fracture risk by 17% in dialysis patients, independent of other bone health factors.

A 2026 analysis of 292 dialysis patients revealed that vitamin D deficiency was associated with nearly double the fracture risk (adjusted hazard ratio 1.87), even though dialysis patients have impaired kidney vitamin D activation.

The Quick Take

  • What they studied: Whether vitamin D levels affect bone fracture risk in people receiving kidney dialysis treatment
  • Who participated: 292 stable outpatients receiving regular hemodialysis (kidney cleaning treatment) at maintenance clinics
  • Key finding: Patients with lower vitamin D levels had nearly double the fracture risk (24.3% fracture rate) compared to those with higher levels (11.9% fracture rate) over 24 months
  • What it means for you: If you receive dialysis, maintaining adequate vitamin D levels may help protect your bones from breaking. Talk to your doctor about vitamin D testing and supplementation as part of your bone health plan.

The Research Details

Researchers followed 292 dialysis patients for a median of 24 months, measuring their vitamin D levels at the start and tracking how many developed broken bones. They used a statistical method called Cox regression to determine whether vitamin D levels independently predicted fracture risk, accounting for other factors that affect bone health like age, weight, and other minerals in the blood.

This approach is stronger than simply comparing two groups because it allows researchers to isolate vitamin D’s effect from other variables. The study was observational rather than experimental—meaning researchers watched what naturally happened rather than randomly assigning people to different vitamin D levels.

Dialysis patients face a unique challenge: their kidneys can’t properly activate vitamin D, even if they have adequate amounts in their blood. This study matters because it shows that the inactive form of vitamin D (25-hydroxyvitamin D) still appears protective, suggesting doctors should monitor and maintain these levels even when kidney activation is impaired.

The study’s strengths include a reasonable sample size (292 patients), a substantial follow-up period (24 months), and use of multivariate analysis to control for confounding factors. The limitation is that it’s observational rather than experimental, so it shows association but not definitive cause-and-effect. The confidence intervals are relatively wide, indicating moderate precision in the estimates.

What the Results Show

During the two-year follow-up, 49 patients (16.8%) experienced new fragility fractures. When researchers divided patients into two groups based on median vitamin D levels, those in the lower group had a 24.3% fracture rate while the higher group had only 11.9%—meaning lower vitamin D was associated with roughly double the fracture risk.

For every 10 nmol/L increase in vitamin D levels, fracture risk decreased by 17% (adjusted hazard ratio 0.83). This relationship held true even after accounting for age, sex, body weight, calcium levels, phosphorus levels, and other factors known to affect bone health in dialysis patients.

The association was statistically significant (p = 0.041 for the group comparison and p = 0.046 for the continuous analysis), meaning these results are unlikely to be due to chance alone.

The study confirmed that vitamin D deficiency is indeed very common in dialysis patients, consistent with previous research. The finding that vitamin D’s protective effect persists despite impaired kidney function suggests that circulating vitamin D itself—not just its activated form—plays an important role in bone health.

In the general population, low vitamin D is well-established as a fracture risk factor. This study extends that finding to dialysis patients, a group where the relationship was previously unclear because their kidneys can’t normally activate vitamin D. The results suggest that vitamin D monitoring and supplementation may be beneficial for this high-risk population, similar to the general population.

The study is observational, so it cannot prove that low vitamin D causes fractures—only that they’re associated. The relatively wide confidence intervals suggest moderate precision. The study didn’t examine specific vitamin D supplementation strategies or doses, so it’s unclear what vitamin D level is optimal or how to best achieve it in dialysis patients. Results may not apply to all dialysis populations, particularly those with different underlying kidney diseases or treatment protocols.

The Bottom Line

Dialysis patients should have their vitamin D levels checked regularly (moderate confidence). If levels are low, supplementation should be considered in consultation with a nephrologist (moderate confidence). Maintaining adequate vitamin D appears to be one modifiable factor that may help reduce fracture risk in this vulnerable population.

This research is most relevant to people receiving hemodialysis, their nephrologists, and dialysis clinic staff. It’s also important for bone health specialists treating dialysis patients. People with early-stage kidney disease should also pay attention, as maintaining vitamin D now may help prevent future bone problems.

Bone health changes occur gradually. Benefits from improved vitamin D levels would likely take months to become apparent, with fracture risk reduction becoming more evident over 12-24 months of consistent adequate levels.

Frequently Asked Questions

Do dialysis patients need vitamin D supplementation?

Research suggests vitamin D supplementation may help reduce fracture risk in dialysis patients. A 2026 study found those with adequate vitamin D had half the fracture rate of those with deficiency. Discuss supplementation with your nephrologist, as dosing must be carefully managed in dialysis patients.

How often should dialysis patients get vitamin D levels checked?

While the research doesn’t specify optimal testing frequency, quarterly monitoring appears reasonable given the importance of maintaining adequate levels. Your nephrologist can recommend the best schedule based on your individual situation and whether you’re taking supplements.

Can vitamin D prevent fractures in people on dialysis?

A 2026 study of 292 dialysis patients found adequate vitamin D was associated with significantly lower fracture rates, suggesting it may help prevent breaks. However, this shows association, not definitive prevention, so vitamin D should be part of a comprehensive bone health strategy.

Why is vitamin D important for dialysis patients if their kidneys don’t work?

Even though dialysis patients can’t activate vitamin D normally, the inactive form circulating in blood still appears protective for bones. This 2026 research suggests monitoring and maintaining adequate circulating vitamin D levels remains important for bone health in this population.

What vitamin D level should dialysis patients aim for?

The study didn’t specify an optimal target level, only that higher levels were protective. Your nephrologist should determine appropriate targets for you, as vitamin D management in dialysis requires careful coordination with calcium, phosphorus, and parathyroid hormone levels.

Want to Apply This Research?

  • Log your vitamin D test results quarterly and track any bone pain, falls, or fractures. Note the date and result of each vitamin D blood test to monitor whether supplementation is raising your levels.
  • Set a reminder to discuss vitamin D supplementation with your nephrologist at your next appointment. If supplementation is recommended, use the app to track daily intake and set reminders for consistent dosing.
  • Create a long-term bone health dashboard tracking: (1) vitamin D test results over time, (2) any falls or injuries, (3) bone pain or weakness, and (4) adherence to vitamin D supplementation. Review trends quarterly with your healthcare provider.

This research describes an association between vitamin D levels and fracture risk in dialysis patients but does not establish definitive cause-and-effect. Dialysis patients have complex mineral and bone metabolism that requires individualized medical management. Do not start, stop, or change vitamin D supplementation without consulting your nephrologist, as vitamin D management in dialysis must be carefully coordinated with calcium, phosphorus, and parathyroid hormone levels to avoid serious complications. This article is for educational purposes and should not replace professional medical advice.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Impact of serum 25-hydroxyvitamin D levels on fragility fractures in patients undergoing chronic hemodialysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2026). PubMed 42509419 | DOI